Ovarian Cancer
Coverage of Ovarian Cancer in the Nexus archive.
- Man returns to ping pong after illness and loss of his wife
Jack Devine, 80, has resumed playing ping pong at a Vermont table tennis club after recovering from myasthenia gravis and the loss of his wife, Gloria, to ovarian cancer. He credits the sport with helping him rebuild physical strength and emotional resilience, guided by advice from expert Amy O’Rourke on gradual recovery and processing grief.
- Man returns to ping pong after illness and loss of his wife
Jack Devine, an 80-year-old man from Shelburne, Vermont, has resumed playing ping pong at a local club after recovering from myasthenia gravis and the loss of his wife, Gloria, to ovarian cancer. He credits the sport with helping him regain physical strength and emotional connection following his hardships.
- Man returns to ping pong after illness and loss of his wife
Jack Devine, 80, has resumed playing ping pong after recovering from myasthenia gravis and the loss of his wife, Gloria, to ovarian cancer. He joined the Champlain Valley Table Tennis Club, where movement and social connection have aided his physical and emotional recovery, according to expert Amy O’Rourke.
- Tennis Legend's Cancer's Back; CDC Emails on RFK Jr. Released; Suicide Attempts Down
Tennis legend Chris Evert announced her ovarian cancer has returned for a third time. The CDC released emails related to RFK Jr.
- ‘Lying flat’ goes mainstream, Singapore mall finds God: 5 weekend reads you missed
The article highlights five stories, including the mainstreaming of the 'lying flat' lifestyle, the rising costs of China's electric car boom, Singapore's notorious mall embracing religion, and the death of Hong Kong TV host Lillian Sze from ovarian cancer.
- Hong Kong TV host Lillian Sze loses battle with ovarian cancer
A Hong Kong television host who spoke four languages and emceed fan meetings for Korean stars died from ovarian cancer less than a month after revealing her diagnosis. Her death was announced on social media, prompting tributes from celebrities and fans.
- New 'prevention vaccine' for people at high risk of bowel and ovarian cancer is announced - and could be rolled out to other forms of the disease in the future
A new 'prevention vaccine' targeting people at high risk of bowel and ovarian cancer has been announced, with potential future expansion to other disease forms. The vaccine aims to prevent rather than treat these cancers.
- Hope for thousands of ovarian cancer patients as new drug which slashes risk of death by a third is made available on the NHS
A new drug that reduces the risk of death by a third for ovarian cancer patients is now available on the NHS, offering hope to thousands. The treatment marks a significant advancement in ovarian cancer care.
- Life-prolonging drug for advanced ovarian cancer gets go-ahead in England
NHS England approved Elahere, the first new drug for chemotherapy-resistant ovarian cancer in over 20 years, offering life-prolonging treatment to hundreds of women. Ovarian cancer affects over 300,000 women annually, with most diagnosed at advanced stages.
- Breakthrough pancreatic cancer treatment could double survival time
A new study on the pancreatic cancer drug daraxonrasib shows it could double survival rates for over 90% of patients. Researchers are investigating its potential effectiveness in lung, ovarian, and colorectal cancers.
- The deadly ovarian cancer signs no one should ignore: Bloating, irregular bleeding and more frequent toilet trips
Ovarian cancer can be identified by several key signs, including bloating, irregular bleeding, and more frequent toilet trips. These symptoms should not be ignored as they can indicate a serious health issue. Early detection is crucial for effective treatment.
- Common cholesterol drug could help treat ovarian cancer, promising new research suggests
Research suggests a common cholesterol drug could help treat ovarian cancer. The study shows promising results, potentially leading to new treatment options. Further research is needed to confirm the findings.
- Common cholesterol drug could help treat ovarian cancer, promising new research suggests
Research suggests a common cholesterol drug could help treat ovarian cancer. The study shows promising results, potentially leading to new treatment options. Further research is needed to confirm the findings.
- My wife died from ovarian cancer at 46 - this was the single symptom she almost overlooked
A 46-year-old woman died from ovarian cancer after overlooking a critical symptom. The article highlights the importance of recognizing early warning signs.
- GSK reports promising early results in ovarian and womb cancer drug trial
GSK reported early trial results showing Mo-Rez reduced or eliminated tumors in 62% of ovarian cancer patients and 67% of endometrial cancer patients. The CEO, Luke Miels, is advancing drug development efforts for the potential blockbuster treatment.
- Repurposed drug may extend survival in aggressive ovarian cancer, trial shows
A drug originally used to treat Cushing’s syndrome, Relacorilant, showed potential in extending survival for patients with platinum-resistant ovarian cancer in a clinical trial. The study suggests repurposing the medication could improve outcomes for aggressive ovarian cancer cases that resist standard platinum-based chemotherapy.
- Marriage status has surprising link to cancer risk, study suggests: 'Clear signal'
A University of Miami study links never-married adults to higher cancer risks, with never-married men showing 70% increased risk and women 85% higher risk. The research highlights significant disparities in cancers like anal, cervical, ovarian, and endometrial cancers across marital statuses.